We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Seagate
STX
$178B
| $79.5K | ﹤0.01% |
1,285
+557
| +77% | +$34K |
|
1627
Corpay
CPAY
$26.4B
| $79.3K | ﹤0.01% |
316
+303
| +2,331% | +$69.1K |
|
1628
DuPont de Nemours
DD
$17.2B
| $79.1K | ﹤0.01% |
882
-122
| -12% | -$10.5K |
|
1629
Celanese
CE
$5.14B
| $78.9K | ﹤0.01% |
681
+322
| +90% | +$34.9K |
|
|
ECHO
1630
EchoStar
ECHO
$27.1B
| $78.2K | ﹤0.01% |
4,510
-10
| -0.2% | -$168 |
|
|
DBTX
1631
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $77K | ﹤0.01% |
20,000
| – | – |
|
1632
Healthpeak Properties
DOC
$14B
| $75.4K | ﹤0.01% |
3,751
-3,215
| -46% | -$66.7K |
|
1633
Fastenal
FAST
$56.3B
| $74K | ﹤0.01% |
2,510
-180
| -7% | -$4.92K |
|
1634
Constellation Energy
CEG
$92B
| $73.1K | ﹤0.01% |
798
+179
| +29% | +$14.8K |
|
|
LGF.A
1635
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $72K | ﹤0.01% |
8,149
-235
| -3% | -$2.47K |
|
1636
FMC
FMC
$1.35B
| $71.6K | ﹤0.01% |
+686
| New | +$77.1K |
|
1637
Hormel Foods
HRL
$11.4B
| $70.4K | ﹤0.01% |
1,751
+374
| +27% | +$15K |
|
|
OSG
1638
Octave Specialty Group
OSG
$213M
| $69.2K | ﹤0.01% |
4,862
+3,924
| +418% | +$57.4K |
|
1639
IDEX
IEX
$16.3B
| $64.6K | ﹤0.01% |
300
-1,620
| -84% | -$341K |
|
1640
Advantage Solutions
ADV
$429M
| $64.4K | ﹤0.01% |
1,102
-55,376
| -98% | -$2.37M |
|
|
GRMN
1641
Garmin
GRMN
$53.4B
| $63.8K | ﹤0.01% |
612
-184
| -23% | -$18.8K |
|
1642
Diamondrock Hospitality Co
DRH
$2.51B
| $63.7K | ﹤0.01% |
7,953
-6,548
| -45% | -$53K |
|
1643
Sylvamo
SLVM
$1.43B
| $63.2K | ﹤0.01% |
1,562
-277,534
| -99% | -$12M |
|
1644
Bath & Body Works
BBWI
$3.37B
| $62.5K | ﹤0.01% |
1,666
-2,016
| -55% | -$73.7K |
|
|
KZR
1645
DELISTED
Kezar Life Sciences
KZR
| $61.4K | ﹤0.01% |
2,505
+2,333
| +1,356% | +$60.7K |
|
1646
Columbus McKinnon
CMCO
$465M
| $61.3K | ﹤0.01% |
1,507
-12
| -0.8% | -$443 |
|
1647
Group 1 Automotive
GPI
$3.13B
| $58.6K | ﹤0.01% |
227
-230
| -50% | -$52.9K |
|
|
LONA
1648
LeonaBio Inc
LONA
$64M
| $58K | ﹤0.01% |
1,966
+908
| +86% | +$25.9K |
|
1649
Gulfport Energy Corp
GPOR
$2.87B
| $55.6K | ﹤0.01% |
529
-241
| -31% | -$22.3K |
|
1650
Mohawk Industries
MHK
$8.65B
| $55.2K | ﹤0.01% |
535
-6,047
| -92% | -$593K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.